Brought to you by 
CSC Pharmaceuticals to license Labopharm's tramadol
08 Dec 2003
Executive Summary
European company CSC Pharmaceuticals (niche-oriented pharma products) signed a binding letter of intent to license eastern European rights to Labopharm Europe's (drug delivery) once-daily formulation of the analgesic tramadol.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Preliminary
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
CSC Pharmaceuticals to license Labopharm's tramadol
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice